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Background and aims: Despite the advances in drugs, side effects of chemotherapy drugs continue to exist. Therefore, more attention has 
been paid to the compounds derived from medicinal herbs and aquatic organisms. This study aimed to investigate the effect of freshwater 
crab hemolymph and meat extract on breast cancer (BC) cell line (4T1).
Methods: After isolation of freshwater crab hemolymph and meat extract, protein concentration and total antioxidant capacity were 
analyzed by bicinchoninic acid (BCA) and cupric reducing antioxidant capacity (CUPRAC) methods. The 4T1 cells and bone marrow 
mesenchymal stem cells (BMSCs) were treated with crab hemolymph (1, 2, 10 mg/mL) and meat extract (0.1, 0.2 and 1 mg/mL), and cell 
survival was analyzed using 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay (MTT) at 48 and 72 hours. Nitric oxide 
(NO) secretion was measured by Griess method. Data were analyzed using one-way analysis of variance (ANOVA). 
Results: Protein concentration of 23.25 mg/mL was shown in crab hemolymph, and 2.3 mg/mL in meat extract. Total antioxidant capacity 
was reported as 1.036 µM/mL and 1.104 µM/mL in crab hemolymph and meat extract, respectively. Cell survival in the 4T1 cells was 
decreased in a dose- and time-dependent manner (P ≤ 0.001). NO secretion of 4T1 cells was decreased after treatment with different 
concentrations of crab hemolymph and meat extract at 48 and 72 hours. Cellular growth was observed in BMSCs after treatment with 
different concentrations of crab hemolymph and meat extract at 48 and 72 hours. 
Conclusion: Since crab hemolymph and meat extract have protein and antioxidant activities, they can have anti-cancer effects on 4T1 cells. 
Keywords: Cell survival, Hemolymph, Meat, Breast neoplasm, Crab
Received: 23 March 2020, Accepted: 30 June 2020, ePublished: 30 March 2021
Introduction 
Breast cancer (BC) is the most common type of cancer 
among women (1). The average age of BC in Iran is 
estimated to be between 40-49 years (2). Different 
chemotherapeutic drugs cause extensive damage to the 
DNA that destroys normal cells, including gastrointestinal, 
bone marrow, and hair follicles. Chemotherapy side 
effects include digestive disorders, reduced count of white 
blood cells, and hair loss. Drug resistance, as a significant 
obstacle, reduces the therapeutic effects of chemotherapy 
agents and avoids the beneficial effects of chemotherapy. 
Consequently, enhancing therapeutic indices by rising 
therapeutic effects and reducing toxicity to normal cells 
is a key issue in cancer treatment (3). Natural products 
have been a significant medicinal source since ancient 
times. Medicine utilizes a wide range of natural products, 
as shown by fact. Approximately, 60% of approved 
cancer therapy medicines are of natural origin. Sources 
of the herbal derivatives are vincristine, etoposide, 
irinotecan, Taxsan, camptothecin, and resveratrol (4-
6). The chemical and biological diversity of the aquatic 
organisms is immense; therefore, it is a great source for the 
discovery of new anticancer drugs (7). The development 
in compounds identification of aquatic as a therapeutic 
agent is still in its infancy due to the shortage of traditional 
medical history compared to the terrestrial habitats. Over 
the past few decades, considerable efforts have been made 
by pharmaceutical companies and academic institutions 
to isolate and identify marine derivatives and new natural 
products (8). Quantitative and qualitative distribution of 
carotenoids in freshwater crab meat (Potamon potamon) 
and shellfish (Charybdis cruciata) from Indian waters was 
investigated. zeaxanthin and astaxanthin existed in in meat 
and shell of marine (9). In one Indian tribe, a study was 
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conducted on the use of several animals and their products 
in traditional medicine. Crab was one of the animals used 
as ashes in the treatment of lung diseases, like cough and 
asthma (10). Crab meat extract as an ingredient in drugs 
used to treat otorrhea and infection of the ear was in Siddha 
medicine (11). The crab Scylla serrata has antibacterial, 
diuretic, and laxative effects and is considered a cardiac 
stimulus (11). The effect of tachyplesin (acid extracts of 
horseshoe crab hemocytes) on hepatocarcinoma cells was 
investigated in a study in China. Tachyplesin inhibited 
the proliferation of hepatocarcinoma cells, altered enzyme 
and antigenic rates, regulated tumor suppressor gene 
expression and differentiation-associated oncogene, and 
decreased a-FP levels (a-FP is an oncofetal antigen and is 
a significant tumor-specific marker for hepatocarcinoma 
detection) (12). We reported the anticancer effects of 
crab shell on BC and prostate cancer cell lines in our 
previous studies. It has been proven that the crab shell 
contains antioxidants, chitosan, and selenium (13-15). 
Apoptosis was increased by increasing the dose and time 
in two cell lines of MCF7 and LNcap, and cell survival 
decreased (13-15). The aim of this study was to investigate 
antiproliferative effects of freshwater crab hemolymph and 
meat extract on BC cell line.
Materials and Methods
The Species and Place of the Freshwater Crabs
The freshwater crabs used in this study were from the 
family of potamidae and the genus potamon and persicum 
species. All crabs were male, and they were hunted from 
the Jajrood River in Tehran, Iran in summer 2018 (Figure 
1).
Preparation of crab hemolymph
After injection of ketamine anesthetic at a dose of 20 mg/
kg to the leg muscle of the crabs (16), the crab body surface 
was disinfected with 70% alcohol. After alcohol drying, 
the feet were separated, hemolymph was originated from 
this part, and the hemolymph in the sterile container was 
collected. With centrifuge at 3000 rpm for 20 minutes, 
the serum was separated and then passed through a filter 
with a diameter of 0.22 micron. Samples were stored at 
-70°C. All extraction steps were performed on ice.
 
Preparation of Crab Meat Extract
After phlebotomy of the crabs, the muscles were removed 
and transferred to the falcon. The samples were immersed 
in 2% potassium chloride for 20 minutes, and then 
centrifuged for 40 minutes at 3200 rpm. Supernatant was 
filtered with 0.22-micron filter.
Determination of total antioxidant capacity in crab 
hemolymph and meat extract by cupric reducing 
antioxidant capacity method
In order to determine the total antioxidant capacity in this 
study, the cupric reducing antioxidant capacity (CUPRAC) 
method and a kit prepared by Kiazist Company of Iran 
were used. In this experiment, the cupric was reduced to 
cuppro in the presence of antioxidants, which produced 
color in the presence of chromogen. The advantage of this 
method is the measurement of antioxidants with thiol 
that are not detected in methods such as iron-based ferric 
reducing antioxidant power (FRAP) assay. The amount 
of absorption is directly related to the antioxidant. In 
this method, standard solution (Trolox) was prepared at 
6 different concentrations. The working solution was also 
prepared according to the kit protocol. To each well from 
a 96-well plate, 30 µL of standards and specimens were 
added, and then 150 µL of working solution was added 
to them. The plate was incubated at room temperature 
for 60 minutes. Finally, the absorbance was read at 450 
nm wavelength via an ELISA reader (Stat Fax 2100, USA) 
(17).
Determination of protein concentration in crab 
hemolymph and meat extract by bicinchoninic acid 
Assay
Bicinchoninic acid (BCA) assay was used to measure 
protein concentration. In this method, protein values 
were determined from the standard curve derived from 
certain protein concentrations. Preparation and dilution 
of standards (6 different concentrations of 0 to 1000 μg/
mL of bovine serum albumin protein) were according to 
the protocols. To each microtube, 10 μL of the samples 
(crab hemolymph and meat extract) and standard were 
added, followed by adding 10 μL of working solution. 
After complete microtube vortex, they were exposed to 
a temperature of 55°C for 25 minutes. After cooling the Figure 1. The crab samples used in the present study. 
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microtubes at room temperature, absorbance was read 
using a nano drop device (NanoDrop 2000, USA) at 560 
nm (Kiazist Company, Iran) (18). After obtaining the 
amount of protein in μg/µL BCA, three concentrations 
from both samples were prepared. Based on several pilot 
tests performed, 1, 2, 10 mg/mL concentrations of crab 
hemolymph and 0.1, 0.2, and 1 mg/mL concentrations of 
crab meat extract were prepared. 
Cell Line and Cell Culture
In this study, BC cell line (4T1) was purchased from the 
cell bank of Pasture Institute in Iran. The cell culture 
consisted of RPMI 1640 (Sigma), 10% fetal bovine serum 
(FBS) (Gibco), and 1% antibiotic Penicillin/Streptomycin 
(Sigma) after de-freezing was put in an incubator at 
37°C and 5% CO2. Bone marrow mesenchymal stem 
cells (BMSCs) were isolated from the femur bone of 
adult Wistar rats aged 6 to 8 weeks and were cultured 
in a DMEM medium (Sigma) containing 10% FBS and 
1% antibiotics. Characterization of stem cells has been 
performed in previous studies (19).
MTT Assay 
To perform MTT assay (3-(4, 5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide), 10 ×103 cells from the 
4T1 and BMSCs were seeded separately in 96-well plates, 
and then 200 µL of the medium was added. Plates were 
incubated at 37°C and 5% CO2 for 24 hours. Different 
concentrations of crab hemolymph (1, 2, 10 mg/mL) and 
meat extract (0.1, 0.2 and 1 mg/mL) were dissolved in 200 
µL serum-free medium; then, the solution was added to the 
respective wells and the plate was incubated again. Control 
group did not receive treatment. The cells in the control 
group were treated with serum-free media to ensure that 
the culture conditions were the same in all groups. MTT 
test was performed after incubation (48 and 72 hours). 
First, a solution of 5 mg/mL of MTT (Sigma) yellow 
powder was prepared. Then, in a dark environment, 20 µL 
of MTT was added to each well and placed in an incubator 
at 37°C for 3 hours. For the dissolution and extraction of 
formazan deposits, 100 µL of DMSO was added to each 
well, and after 30 minutes, each well was read by ELISA 
reader (Stat Fax 2100, USA) at wavelengths of 570 and 
630 nm. The percentage of living cells was calculated 
using the appropriate formula for each concentration (13).
Cell viability (%) = [A570- 630(sample)/A (control)] ×100
Nitric Oxide Assay
Nitric oxide (NO) is a cell messenger and in cancer 
increase NO levels (20). The Griess method was used to 
measure NO. Supernatant 4T1 cells that were exposed 
at different doses of crab hemolymph and meat extract 
at 48 and 72 h intervals were collected. Supernatant was 
deproteinized by zinc sulfate, and then centrifuged for 
12 minutes at 4℃ and 12000 rpm. Next, to 100 µL of 
this supernatant, we added 100 µL of Vanadium chloride 
(Sigma), 50 µL sulfanilamide (Sigma), and 50 µL NEDD 
N-(1- Naphthyl) ethylenediamine dihydrochloride 
(Sigma) and incubated the mixture for 30 minutes at 37°C 
temperature. Sodium nitrate (Sigma) standard solution 
was prepared at concentrations of 0, 6, 12, 25, 50, 100, 
and 200 mM. Standard and samples were read by 540 and 
630 nm by the Eliza Reader (Stat Fax 2100, USA)(13).
Statistical Analysis 
One-way analysis of variance (ANOVA) with post hoc 
Tukey HSD test was used for data analysis. Data were 
analyzed by the GraphPad Prism software (version 8). 
Mean differences were considered significant at P ≤ 0.05. 
Each experiment was performed 3 times and the mean of 
the results was evaluated.
Results
Total Antioxidant Capacity by CUPRAC Method
The standard total antioxidant capacity (TAC) was plotted 
and the antioxidant values of each sample, including the 
crab hemolymph and the meat extract were 1.036 µM/
mL and 1.104 µM/mL, respectively (Figure 2). The results 
showed that the TAC in the meat extract was higher than 
hemolymph.
Protein concentration by BCA method
The total protein measurements based on different 
concentrations of standard solutions, absorbance, and 
standard curve were 23.25 mg/mL in crab hemolymph and 
2.3 mg/mL in crab meat extract. The above concentrations 
were calculated according to the standard chart (Figure 3) 
and the corresponding formula. The results showed that 
the protein concentration of crab hemolymph was higher 
than meat extract.
MTT Assay
The effect of crab hemolymph on 4T1 and BMSCs
Comparison of the viability of the 4T1 cell line by MTT 
assay during 48 and 72 hours showed that the cell survival 
was reduced by increasing the dose of the crab hemolymph 
Figure 2. The standard curve for determining the total antioxidant 
capacity (TAC) by CUPRAC assay.
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compared to the control group. There was a significant 
difference between the groups (P ≤ 0.001***, P ≤ 0.02*). 
The data is shown as mean ± SD. The BMSCs treated 
with crab hemolymph were proliferated. IC50 dose of crab 
hemolymph was 1 mg/mL at 72 hours (4T1) (Figure 4a 
and b).
The effect of meat extract on 4T1 and BMSCs
After 48 and 72 hours, cell viability with increased dose 
and time of effect of crab meat extract on 4T1 increased 
compared to control group, and there was a significant 
difference between the groups (P ≤ 0.001***, P ≤ 0.02*). 
The data is shown as mean ± SD. However, increased 
growth was seen in BMSCs treated with meat extract. 
IC50 dose of crab meat extract was 0.1 mg/mL at 72 hours 
(4T1) (Figures 5a and 5b).
NO Assay
NO secretion from 4T1 cells significantly decreased in 
response to different concentrations of crab hemolymph 
and meat extract in a dose- and time-dependent manner. 
There was a significant difference between the groups 
(P ≤ 0.001***, P ≤ 0.02*). The data is shown as mean ± SD 
(Figures 6 and 7). 
As the results show, crab meat extract reduced the 
amount of NO secretion, which was higher than the 
groups treated with crab hemolymph.
Discussion
This study investigated crab hemolymph and meat extract 
as an anticancer source of marine resources. Natural 
products are an alternative to chemotherapy drugs without 
side effects or less complications. Many countries are using 
crabs in their diet. Antioxidant capacity was reported in 
Figure 4. 4T1 (a) and BMSCs (b) Viability (%) in Different Concentration of Crab Hemolymph (MTT Assay). 
Cell viability in the 4T1 cancer cell line was decreased in a dose- and time-dependent manner. In the BMSCs, cell growth was increased in 
a dose- and time-dependent manner. There is significant difference between the groups (P ≤ 0.001***, P ≤ 0.02*). The data is shown as mean 
± SD.
Figure 5. 4T1 Cells (a) and BMSCs (b) Viability (%) in Different Concentration of Crab Meat Extract by MTT Assay
Cell viability in the 4T1 cancer cell line was decreased in a dose- and time-dependent manner. In the BMSCs, cell growth was increased in 




Figure 3. The standard curve for determining the concentration of 
protein by BCA assay.
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crab hemolymph and meat extract. Several studies have 
measured the antioxidant capacity of different herbal 
extracts (21). In a study, the effect of various extracts 
of flower, stem, leaf, and seedlings of Indigo plant on 
different classes of cancer cells, growth inhibition of 
these cells with different concentrations of the extracts 
was reported. Considering the total antioxidant capacity 
of these extracts and the amounts obtained, the control 
of cancer cells was directly related to the antioxidant 
capacity (22). Antioxidants found in various vitamins and 
minerals have been shown to inhibit cancer. Many studies 
in this area are in the clinical trial stage (23,24). Since 
these samples contain antioxidants, and there are also 
many studies on the presence of antioxidants in seafood 
(25), they can be considered as complementary therapies 
in combination with treatments such as chemotherapy, 
radiotherapy, and surgery in the treatment of cancer (21). 
The antioxidant capacity calculated from both of the 
above samples was lower than that of many plant extracts, 
but the inhibitory effect of cancer cells was significantly 
higher (17,21,26); this may be due to a specific type of 
antioxidant that is effective in controlling cancer. This 
result is similar to the findings of the present report. 
As witnessed, in the lower concentration of protein in 
the meat extract, cancer inhibition was found to be 
higher than that of the hemolymph, which in addition 
to the role of antioxidant could be due to the presence 
of certain proteins or mineral elements. The results of 
a study on the Brachyuran crab hemolymph proteins 
showed that the effect of nutrition in different regions 
contributes to the amount of crab hemolymph proteins. 
Hemolymph proteins have unique compounds in marine 
invertebrate like crab; they do not contain albumin and 
immunoglobulin, and their protein constituents change 
in relation to the physiological and functional state of the 
animal (27). On the other hand, numerous studies have 
been carried out on the anticancer effects of proteins. 
Family Forkhead box proteins, for example, are involved 
in transcriptional regulation that control a wide range of 
physiological processes. Disruptions in the function of this 
protein play a role in promoting cancer. This protein can 
be used directly or indirectly through biomarkers to treat 
cancer (28). The expression of genes is also effective in the 
development of cancer; for example, the expression of a 
specific isofarm of the ZFX gene has a positive correlation 
with tumor size (29). Therefore, the protein in the samples 
may be one of the possible causes of cancer inhibition. 
This finding is close to the present report’s results. In this 
study, the effect of freshwater crab hemolymph and meat 
extract on 4T1cell line and BMSCs were evaluated by 
MTT assay. In studies conducted on crab so far, the type 
of crab has not been studied in terms of the anticancer 
effect of hemolymph and meat extracts, and only the 
anticancer effects of the shell of this type of crab have been 
investigated in our previous studies (13,14). Different 
doses of crab hemolymph and meat extract were prepared 
and applied to 4T1 cells in two intervals. IC50 dose of crab 
hemolymph and meat extract was 1 mg/mL and 0.1 mg/
mL at 72 hours, respectively. Cellular growth was observed 
in BMSCs treated with crab hemolymph and meat extract. 
Therefore, these two samples had no effect on normal cells. 
Since both samples contain proteins and proteins have 
anticancer properties, in this study both extracts decreased
the survival of cancer cells. On the contrary, the amount 
of protein concentration from the crab hemolymph was 
greater than meat extract; but the survival of cancer cells 
Figure 6. The standard curve for determining the nitric oxide (NO) 
assay. 
Figure 7. The amount of NO (µM) secretion of 4T1 cells after 48 and 72 h of treatment with different concentrations of crab hemolymph (a) and 
meat extract (b). NO secretion of 4T1 cells decreased in dose and time-dependent manner (P ≤ 0.001 ***). The data is shown as mean ± SD.
a b
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was significantly reduced by the meat extract, which can 
be attributed to the amount of TAC explained by these 
two samples. In one study, the effects of paclitaxel on 
several levels of BC were investigated. The up-regulation 
of FoxO3a by paclitaxel increased levels of protein and 
caused apoptosis in BC cells (30). Resveratrol is able 
to inhibit the growth of BC cells with its antioxidant 
properties (5). Therefore, the proteins and antioxidants 
in the crab hemolymph and meat extracts may prevent 
cancer in 4T1 cells. The above studies (5,30) were in line 
with our studies. NO is considered to be a free radical 
that causes an increase in oxidative stress (20). A study 
reported that NO plays a role in enhancing angiogenesis 
factors and is capable of producing metastasis in BC (31). 
In other studies conducted on various cancers such as 
breast, prostate, and liver treated with different extracts, 
NO secretion decreased (13,14,32). In our study, both 
samples were able to reduce NO secretion in the BC cell 
line, but the amount of NO released in the crab meat 
extract-treated cells was much higher than that of the crab 
hemolymph. Our results were in line with other studies in 
this field.
Conclusion
The different doses of crab hemolymph and meat extract 
reported the growth inhibitory effects on BC cells (4T1). 
TAC was also reported in the above samples. NO secretion 
in BC cells decreased by using crab hemolymph and meat 
extract with dose and time increase. Therefore, crab 
hemolymph and meat extract with antioxidant ability can 
inhibit BC cells. It is recommended that future studies 
monitor crab hemolymph and meat extract from the 
aspect of molecular and signaling pathways.
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